Cargando…
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model
Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase, has anti-tumor properties in various carcinoma models. Diisopropylamine dichloroacetate (DADA), an over-the-counter drug for chronic liver disease, is a derivative of DCA. To date, few studies have evaluated the anticancer potenti...
Autores principales: | Su, Lei, Zhang, Hailin, Yan, Chen, Chen, Aiping, Meng, Gang, Wei, Jiwu, Yu, Decai, Ding, Yitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323187/ https://www.ncbi.nlm.nih.gov/pubmed/27582548 http://dx.doi.org/10.18632/oncotarget.11609 |
Ejemplares similares
-
Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels
por: Dong, Gaochao, et al.
Publicado: (2016) -
Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin
por: Ishiguro, Tatsuaki, et al.
Publicado: (2022) -
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
por: Meng, Gang, et al.
Publicado: (2019) -
Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma
por: Li, Chunyan, et al.
Publicado: (2014) -
Diisopropylamine Dichloroacetate, a Novel Pyruvate Dehydrogenase Kinase 4 Inhibitor, as a Potential Therapeutic Agent for Metabolic Disorders and Multiorgan Failure in Severe Influenza
por: Yamane, Kazuhiko, et al.
Publicado: (2014)